Cowen and Company’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Cowen and Company’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-150,500	Closed	-$8K	–	871
2021 Q2	$8K	Buy	150,500 +120,800	+407%	+$3.08M	﹤0.01%	550
2021 Q1	$30K	Buy	+29,700	New	+$900K	﹤0.01%	431

Cowen and Company's CNST Position: Q2 2021 in Review

Cowen and Company sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 4,813 shares — an estimated $123K sold.

Cowen and Company first reported a position in CNST in Q1 2021 and held it in 1 quarter. The position peaked at $113K in Q1 2021. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

Cowen and Company reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Cowen and Company sold 4,813 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $123K.
Cowen and Company first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
Cowen and Company's Constellation Pharmaceuticals, Inc. position peaked at $113K in Q1 2021.
153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Cowen and Company's 13F filing for Q2 2021, filed 13 Aug 2021.